Café

© 2026 Longbridge｜Terms of Service Privacy Policy

600351

600351

----

LongbridgeAI

The A-share innovative drug concept continues to be strong, with YABAO PHARM.CORP hitting the limit up, and JENKEM, HSGC, YKYY, MEDISAN, HITECK, and others leading in gains

Wallstreetcn

Jul 24, 2025 at 01:32 AM

The A-share innovative drug concept continues to be strong, with YABAO PHARM.CORP hitting the limit up, and JENKEM, HSGC, YKYY, MEDISAN, HITECK, and others leading in gains

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

YABAO PHARM.CORP

SH600351

-1.63%

JENKEM

SH688356

-3.03%

HSGC

SH600774

-2.80%